Agranulocytosis and Anemia during Treatment of Seizure with Phenytoin

Authors

  • Wichai Santimaleeworagun
  • Kannadit Prayongratana
  • Chantrapa Sriswasdi
  • Wichai Prayoonwiwat

Keywords:

Phenytoin, Agranulocytosis, Anemia

Abstract

Phenytoin has been widely used in clinical practice with a good efficacy but its adverse drug reaction is also incessantly reported. A 72-year-old man with lobar hemorrhage at the left parieto-occipital lobe and old ischemic stroke who developed seizure 3 times and phenytoin was used to control meanwhile, his seizure was investigated. After 22 days of phenytoin administration, his complete blood count revealed bicytopenia including white blood cell count of 1.3 x 109/L with an absolute neutrophil count of 0.338 x 109/L and hemoglobin level of 10.1 g/dL. The bone marrow aspiration and trephine biopsy confirmed markedly decreased of erythroid and myeloid precursors. He was diagnosed with agranulocytosis most likely from phenytoin. Phenytoin was discontinued and substituted by levetiracetam. Filgrastim was also prescribed for neutropenia. Nine days later, he recovered from agranulocytosis without any serious infection.

Downloads

Download data is not yet available.

References

1. Karthikeyan M, Saquib AAK, Karthikeyan D. Therapeutic applications of phenytoin. Asian J Pharm Clin Res. 2009;2:1-14.
2. Abou-Khalil BW. Antiepileptic Drugs. Continuum (Minneap Minn). 2016;22(1 Epilepsy):132-56.
3. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C.Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ. 1997;315:1582-7.
4. Gilad R. Management of seizures following a stroke: what are the options? Drugs Aging. 2012;29:533-8.
5. Garrard J, Harms S, Hardie N, Eberly LE, Nitz N, Bland P, et al. Antiepileptic drug use in nursing home admissions. Ann Neurol. 2003;54:75-85.
6. Rawanduzy A, Sarkis A, Rovit RL. Severe phenytoin-induced bone marrow depression and agranulocytosis treated with human recombinant granulocyte-macrophage colony-stimulating factor.
Case report. J Neurosurg. 1993;79:121-4.
7. Sharafuddin MJ, Spanheimer RG, McClune GL. Phenytoin-induced agranulocytosis: a nonimmunologic idiosyncratic reaction? Acta Haematol. 1991;86:212-3.
8. Greene EM, Hagemann TM. Drug-Induced Hematologic Disorders.In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: A Pathophysiologic Approach, 10th
ed. New York, NY: McGraw-Hill Education [Internet]. 2017 [cited 2018 Aug 30]. Available from: https://accesspharmacy.mhmedical.com/content.aspx?bookid=1861&sectionid=146079796.
9. Uetrecht J, Zahid N. N-chlorination of phenytoin by myeloperoxidase to a reactive metabolite. Chem Res Toxicol. 1988;1:148-51.

Downloads

Published

2018-09-26

Issue

Section

รายงานผู้ป่วย (Case report)